Curaleaf Holdings, Inc. KURLF CURA completelyedit its agreement to acquire a 55% stake in Four 20 Pharma GmbHa German manufacturer and distributor of medical cannabis fully licensed according to EU-GMP and GDP.
Boris JordanExecutive Chairman of Curaleaf, stated: “We are delighted to close the transaction with Four 20 Pharma and I am personally delighted to welcome Torsten and Thomas to the Curaleaf family in one of the industry’s crucial global markets. Curaleaf is the only MSO in the US uniquely positioned to take advantage of this opportunity.”
With the closing of the transaction, Curaleaf has solidified a strategic path to acquire full control of Four 20 Pharma after two years of adult use in Germany, scheduled to begin in early 2024.
Opening of Allentown Pharmacy
The Company is opening its Allentown pharmacy at 1801 Airport Rd, Allentown, PA 18109. Curaleaf Allentown is the Company’s sixth new location to open in Keystone State this year, expanding its retail presence to 18 locations in Pennsylvania and 137 nationwide.
Curaleaf Allentown offers a curated selection of products from across the company’s portfolio of brands, including base, select and Curaleaf. Patients can choose from a wide range of products including Select Elite, Select Elite Live, Grassroots Full Spectrum and Strain Specific RSO, Grassroots Full Spectrum and Strain Specific RSO Capsules, Grassroots Pre-Pack, Curaleaf Pre-Pack and Grassroots Concentrate.
The new dispensary celebrated its provisional opening on September 17 and is scheduled to officially open on September 29. Curaleaf commemorated its recent retail opening with a $5,000 donation Coalition for Urban Affairsa non-profit organization dedicated to improving the quality of life and building wealth in marginalized communities.
In addition to Curaleaf Allentown, the company serves…
